The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment.
Article in Journal of Alzheimer's Disease (January 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Incident dementia in kidney transplantation recipients: a matched comparative nationwide cohort study in South Korea
Article in Kidney Research and Clinical Practice (July 2023)
Adult Renal Dysfunction and Risk of Dementia or Cognitive Decline: Brain-Kidney Axis Hypothesis Based on a Systematic Review and Meta-Analysis
Article in The Journal of Prevention of Alzheimer's Disease (January 2023)